A Comparison of Aerius Continuous Treatment Versus Aerius PRN for Chronic Idiopathic Urticaria (Study P03147)
Conditions: Urticaria; Chronic Idiopathic UrticariaInterventions: Drug: desloratadine; Drug: desloratadineSponsor: Merck Sharp & Dohme Corp.Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2008 Category: Research Source Type: clinical trials
Efficacy and Safety of Desloratadine vs. Fexofenadine 180 mg. vs. Placebo for Treating Seasonal Allergic Rhinitis (SAR)(Study P04053)(COMPLETED)
Condition: Seasonal Allergic RhinitisInterventions: Drug: desloratadine; Drug: fexofenadine; Drug: placeboSponsor: Merck Sharp & Dohme Corp.Completed - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2008 Category: Research Source Type: clinical trials
The Effect of Desloratadine and Levocetirizine on Nasal Obstruction (Study P03609)
Condition: Allergic RhinitisInterventions: Drug: desloratadine; Drug: levocetirizineSponsor: Merck Sharp & Dohme Corp.Completed - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 30, 2008 Category: Research Source Type: clinical trials
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: AllergiesInterventions: Drug: Desloratadine; Drug: Zyrtec® (cetirizine)Sponsor: Merck Sharp & Dohme Corp.Completed - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 26, 2008 Category: Research Source Type: clinical trials
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: AllergiesInterventions: Drug: Desloratadine; Drug: Zyrtec® (cetirizine)Sponsor: Merck Sharp & Dohme Corp.Completed - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials
Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)
Condition: AllergiesInterventions: Drug: Desloratadine; Drug: Zyrtec® (cetirizine)Sponsor: Merck Sharp & Dohme Corp.Completed - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials
Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)
Condition: AllergiesInterventions: Drug: Desloratadine; Drug: Zyrtec® (cetirizine)Sponsor: Merck Sharp & Dohme Corp.Completed - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2008 Category: Research Source Type: clinical trials
